Pros: Enhanced Healing: BPC-157 can potentially speed up the recovery process from injuries and surgeries
13 ClinicalTrials.govTrial registry for full-length thymosin beta-4 (e.g., dermal and ocular indications)
In fact, it has been suggested as a s potential treatment for conditions such as COVID-19, as it improves vascular integrity, and immune response and reduces proinflammatory profiles, which reduces critical levels of disease
Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection
User 3, recovering from a complete ACL and LCL rupture at 21 years old, used 500mcg split as 250mcg every 12 hours and discontinued at day 40
Akkermansia muciniphila is beneficial to a mouse model of Parkinsons disease, via alleviated neuroinflammation and promoted neurogenesis, with involvement of SCFAs